Search for: "Daubert v. Merrell Dow Pharmaceuticals, Inc." Results 141 - 160 of 218
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
28 Jul 2015, 11:52 am by Schachtman
Merrell Dow Pharmaceuticals Inc., 43 F.3d 1311, 1320 (9th Cir.), cert. denied 516 U.S. 869 (1995) [Daubert II]. [read post]
31 Mar 2016, 8:09 am by Jetta Sandin and Jay Levine
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993), nor did Tyson offer a rebuttal expert witness. [read post]
28 Jun 2012, 5:52 am
Merrell Dow Pharmaceuticals apply to expert evidence offered at class certification? [read post]
28 Jun 2012, 5:52 am
Merrell Dow Pharmaceuticals apply to expert evidence offered at class certification? [read post]
1 May 2008, 11:21 am
Beretta USA, Inc., No. 05-6942-cv (2d Cir. [read post]
24 Aug 2010, 11:34 am
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993), in which the Court instructed district courts to function as gatekeepers and permit only reliable and relevant expert testimony to be presented to the jury. [read post]
11 May 2020, 1:09 am by Schachtman
That was the tradition that stood in active need of reform when Daubert was decided in 1993. [read post]
3 Jan 2015, 3:47 pm by Robert Kreisman
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993) and granted BNSF’s motion for summary judgment. [read post]